Tofacitinib for celiac disease and microscopic colitis: killing two birds with one stone
Acta Gastro Enterologica Belgica2023Vol. 86(2), pp. 374–376
Citations Over TimeTop 24% of 2023 papers
Abstract
Microscopic colitis is a chronic inflammatory condition of the colon. Firstline treatment consists of budesonide, with the consideration of biological agents in refractory cases. Celiac disease is a chronic immune mediated and gluten-induced enteropathy, with treatment consisting of a gluten-free diet. There is an association between microscopic colitis and instead of xand celiac disease, especially in refractory cases they can coincide. In this manuscript, we report for the first time the efficacy of tofacitinib, a pan Janus kinase inhibitor, in the treatment of concomitant microscopic colitis and celiac disease, resulting in persistent clinical and histological remission.
Related Papers
- → Gluten-Sensitive Enteropathy(1976)37 cited
- → Budesonide in the Treatment of Collagenous Colitis(1998)34 cited
- → Use of budesonide in the treatment of microscopic colitis(2010)4 cited
- Treatment of Allergic Enteropathy in a 7-year-old Girl with Controlled-release Budesonide(2003)